Home / Japan / BrightPath Biotherapeutics Co.,Ltd.
BrightPath Biotherapeutics Co.,Ltd.
Short position disclosed on September 16, 2026.
4.09% of the capital sold short
3 disclosing funds
45 disclosures on record
Evolution of the disclosed total
0%2%4%6%
Aug 13Aug 23Sep 2Sep 12
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Nomura International plc | 1.99% | new | September 16, 2026 | |
| Barclays Capital Securities Ltd | 1.11% | -0.71 pt | September 16, 2026 | |
| JPM Securities Japan Co Ltd. | 0.99% | new | September 16, 2026 |
Get the moves on BrightPath Biotherapeutics Co.,Ltd. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 45 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- ReYuu Japan Inc. 12.36% of the capital sold short
- Towa Corporation 10.49% of the capital sold short
- TESS Holdings Co.,Ltd. 6.97% of the capital sold short
- Unitika LTD. 6.96% of the capital sold short
- Jibannet Holdings Co.,Ltd. 6.90% of the capital sold short
- Nomura Micro Science Co.,Ltd. 6.52% of the capital sold short
- Toyo Engineering Corporation 6.29% of the capital sold short
- JSH Co.,Ltd. 5.97% of the capital sold short
- Datasection Inc. 5.83% of the capital sold short
- Def consulting,inc. 5.76% of the capital sold short
- Tri Chemical Laboratories Inc. 5.71% of the capital sold short
- Toho Zinc Co.,Ltd. 5.27% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, BrightPath Biotherapeutics Co.,Ltd., source JPX, data as at September 16, 2026, https://www.quivad.com/action/brightpath-biotherapeutics-co-ltd